Preoperative | - Preoperative multidisciplinary evaluation |
- Cardiac risk stratification with transthoracic echocardiography and stress thallium if clinically indicated | |
- Optimization of medical comorbidities | |
- Education of patients and families and informed consent | |
- Urea, creatinine, electrolytes, estimated glomerular filtration rate, albumin, liver function tests, ferritin, hemoglobin, platelet white cell count, prothrombin time, fasting glucose, activated partial thromboplastin time, fibrinogen, chest x-ray, EKG | |
Intraoperative | Day of surgery |
- Two hours fasting for clear fluids, 6 h fasting for light meal | |
Anesthesia protocol | |
- No preoperative IV fluid loading | |
- Spinal analgesia: intrathecal morphine (200-400μg) | |
- Induction: propofol (1 mg/kg), fentanyl (3 μg/kg) | |
- Maintenance: volatile or propofol infusion (BIS of 40–60) | |
- Intraoperative analgesia: remifentanil infusion (0.1–0.3 μg/kg/hr) | |
- Prophylactic thromboembolic prophylaxis (enoxaparin 40 mg SC) | |
- Antibiotic prophylaxis (ceftriaxone/ampicillin/metronidazole) | |
- Pre-hepatic transection phase: fluid restriction | |
- Hepatic transection phase: fluid restriction, low central venous pressure (< 8 mmHg) using reverse Trendelenburg positioning and glyceryl trinitrate IVI infusion (5–20 μg/min) if required | |
- Post-hepatic transection phase: restoration of euvolemia | |
- Paracetamol 1 g IV | |
- Removal of nasogastric tube at completion of surgery | |
Day of surgery and & Postoperative Day 1 | Analgesia |
- Patient controlled analgesia with fentanyl or oxycodone | |
- Fentanyl infusion (10 μg/hr) IV | |
- Ketamine infusion 0.05–0.1 mg/kg//hr. IV | |
- Paracetamol 1 g IV/po TDS | |
Fluid intervention | |
- Oral fluids encouraged and soft diet | |
- Balanced crystalloid maintenance therapy: 125 ml/hr | |
- Albumex 4% 250 ml boluses at discretion of clinicians | |
Other | |
- Metoclopramide 15 mg IV TDS | |
- Potassium and magnesium supplementation | |
- Vitamin K 10 mg daily | |
- Continue antibiotics for 24 h | |
- Dihydrogen phosphate ions (14.5 mmol IV TDS) | |
- Pantoprazole 40 mg IV/po daily | |
- Heparin 5000 IU SC BD | |
- Physiotherapy: early mobilization within 6 h of surgery | |
Postoperative Day 2 | Analgesia |
- Patient controlled analgesia with fentanyl or oxycodone | |
- Ketamine infusion ceased | |
- Paracetamol 1 g po TDS | |
- Tramadol 50–100 mg IV/po QID prn | |
Fluid intervention | |
- Oral fluids encouraged and soft diet | |
- Maintenance fluid therapy reduced to 83 mls/hr | |
Other | |
- Metoclopramide 15 mg IV TDS | |
- Pantoprazole 40 mg po daily | |
- Vitamin K 10 mg daily | |
- Dihydrogen phosphate ions (14.5 mmol IV TDS) | |
- Potassium and magnesium supplementation | |
- Physiotherapy: early mobilization TDS | |
- Antithrombotic prophylaxis | |
- Urinary catheter removed | |
Analgesia | |
- Patient Controlled Analgesia with fentanyl or oxycodone | |
- Stop ketamine infusion | |
- Strict QID paracetamol | |
- PRN tramadol | |
Fluid intervention | |
- Aim for neutral fluid balance | |
- Reduce maintenance fluid therapy to 42 mls/hr. | |
- Soft ward diet | |
Other | |
- Removal of central venous catheter | |
- Removal of urinary catheter | |
- Daily weight | |
- Strict metoclopramide 15 mg IV TDS | |
- Potassium and magnesium supplementation | |
- Pantoprazole 40 mg daily | |
- Use of diuretic if positive fluid balance (frusemide 10–20 mg) | |
- Vitamin K 10 mg daily | |
- Dihydrogen phosphate ions (14.5 mmol IV TDS) | |
- Continue antithrombotic prophylaxis | |
- Physiotherapy: continue mobilization TDS | |
Postoperative Day 3 to hospital discharge | Analgesia |
- Patient controlled analgesia ceased | |
- Oxycodone (IR) 10 mg 4 hourly prn | |
- Paracetamol 1 g prn TDS | |
- Tramadol 50–100 mg prn TDS | |
Fluid intervention | |
- Advance oral diet | |
Other | |
- Daily weight | |
- Potassium and magnesium supplementation | |
- Pantoprazole 40 mg PO | |
- Continue antithrombotic prophylaxis | |
- Coloxyl 100 mg BD | |
- Physiotherapy: continue mobilization TDS |